- Home
- SELF vs MURA Comparison
SELF vs MURA Comparison
Compare SELF & MURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SELF
- MURA
- Stock Information
- Founded
- SELF 1983
- MURA 2013
- Country
- SELF United States
- MURA Ireland
- Employees
- SELF N/A
- MURA N/A
- Industry
- SELF Real Estate Investment Trusts
- MURA
- Sector
- SELF Real Estate
- MURA
- Exchange
- SELF Nasdaq
- MURA Nasdaq
- Market Cap
- SELF 57.5M
- MURA 62.2M
- IPO Year
- SELF N/A
- MURA N/A
- Fundamental
- Price
- SELF $5.13
- MURA $3.45
- Analyst Decision
- SELF
- MURA Strong Buy
- Analyst Count
- SELF 0
- MURA 4
- Target Price
- SELF N/A
- MURA $16.00
- AVG Volume (30 Days)
- SELF 13.1K
- MURA 56.9K
- Earning Date
- SELF 11-08-2024
- MURA 11-13-2024
- Dividend Yield
- SELF 5.68%
- MURA N/A
- EPS Growth
- SELF 39.82
- MURA N/A
- EPS
- SELF 0.28
- MURA N/A
- Revenue
- SELF $12,319,724.00
- MURA N/A
- Revenue This Year
- SELF N/A
- MURA N/A
- Revenue Next Year
- SELF N/A
- MURA N/A
- P/E Ratio
- SELF $18.36
- MURA N/A
- Revenue Growth
- SELF 0.38
- MURA N/A
- 52 Week Low
- SELF $4.01
- MURA $2.88
- 52 Week High
- SELF $5.85
- MURA $6.25
- Technical
- Relative Strength Index (RSI)
- SELF 53.20
- MURA 48.79
- Support Level
- SELF $5.10
- MURA $3.31
- Resistance Level
- SELF $5.29
- MURA $3.66
- Average True Range (ATR)
- SELF 0.15
- MURA 0.18
- MACD
- SELF 0.02
- MURA -0.01
- Stochastic Oscillator
- SELF 57.89
- MURA 45.45
About SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.